Literature DB >> 15695097

The highways and byways of prion protein trafficking.

Vincenza Campana1, Daniela Sarnataro, Chiara Zurzolo.   

Abstract

Prions are defined as infectious agents that comprise only proteins and are responsible for transmissible spongiform encephalopathies (TSEs)--fatal neurodegenerative diseases that affect humans and other mammals and include Creutzfeldt-Jacob disease in humans, scrapie in sheep and bovine spongiform encephalopathy in cattle. Prions have been proposed to arise from the conformational conversion of the cellular prion protein PrP(C) to a misfolded form termed PrP(Sc) that precipitates into aggregates and fibrils. The conversion process might be triggered by interaction of the infectious form with the cellular form or it might result from a mutation in the gene encoding PrP(C). Exactly how and where in the cell the interaction and the conversion of PrP(C) to PrP(Sc) occur, however, remain controversial. Recent studies have shed light on the intracellular trafficking of PrP(C), the role of protein mis-sorting and the cellular factors that are thought to be required for the conformational conversion of prion proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695097     DOI: 10.1016/j.tcb.2004.12.002

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  56 in total

1.  The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein.

Authors:  David R Taylor; Nigel M Hooper
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

Review 2.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

Review 3.  On the key role played by altered protein conformation in Parkinson's disease.

Authors:  L F Agnati; E Baldelli; N Andreoli; A S Woods; V Vellani; D Marcellino; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-06-05       Impact factor: 3.575

4.  Trafficking of PrPc to mitochondrial raft-like microdomains during cell apoptosis.

Authors:  Maurizio Sorice; Vincenzo Mattei; Vincenzo Tasciotti; Valeria Manganelli; Tina Garofalo; Roberta Misasi
Journal:  Prion       Date:  2012-07-30       Impact factor: 3.931

Review 5.  Protein quality control in neurodegeneration: walking the tight rope between health and disease.

Authors:  E M Hol; W Scheper
Journal:  J Mol Neurosci       Date:  2007-03-24       Impact factor: 3.444

6.  Doppel and PrPC co-immunoprecipitate in detergent-resistant membrane domains of epithelial FRT cells.

Authors:  Anna Caputo; Daniela Sarnataro; Vincenza Campana; Maddalena Costanzo; Alessandro Negro; M Catia Sorgato; Chiara Zurzolo
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

Review 7.  The ubiquitin-proteasome system in spongiform degenerative disorders.

Authors:  Brandi R Whatley; Lian Li; Lih-Shen Chin
Journal:  Biochim Biophys Acta       Date:  2008-08-23

8.  Lipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cells.

Authors:  Daniela Sarnataro; Anna Caputo; Philippe Casanova; Claudia Puri; Simona Paladino; Simona S Tivodar; Vincenza Campana; Carlo Tacchetti; Chiara Zurzolo
Journal:  PLoS One       Date:  2009-06-08       Impact factor: 3.240

9.  Identification of the RGG box motif in Shadoo: RNA-binding and signaling roles?

Authors:  Susan M Corley; Jill E Gready
Journal:  Bioinform Biol Insights       Date:  2008-11-19

10.  Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.

Authors:  David R Taylor; Isobel J Whitehouse; Nigel M Hooper
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.